Cigna Investments’s Procter & Gamble PG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.23M | Sell |
22,337
-298
| -1% | -$45.2K | 0.5% | 28 |
|
|
2025
Q4 | $3.24M | Sell |
22,635
-261
| -1% | -$38.5K | 0.47% | 30 |
|
|
2025
Q3 | $3.52M | Sell |
22,896
-180
| -0.8% | -$28.1K | 0.5% | 28 |
|
|
2025
Q2 | $3.68M | Sell |
23,076
-615
| -3% | -$100K | 0.63% | 21 |
|
|
2025
Q1 | $4.04M | Sell |
23,691
-395
| -2% | -$66.2K | 0.75% | 19 |
|
|
2024
Q4 | $4.04M | Sell |
24,086
-214
| -0.9% | -$36.4K | 0.71% | 20 |
|
|
2024
Q3 | $4.21M | Sell |
24,300
-433
| -2% | -$73.5K | 0.74% | 18 |
|
|
2024
Q2 | $4.08M | Sell |
24,733
-173
| -0.7% | -$28.3K | 0.75% | 18 |
|
|
2024
Q1 | $4.04M | Sell |
24,906
-199
| -0.8% | -$31.2K | 0.76% | 21 |
|
|
2023
Q4 | $3.68M | Sell |
25,105
-86
| -0.3% | -$12.7K | 0.76% | 21 |
|
|
2023
Q3 | $3.67M | Sell |
25,191
-3,354
| -12% | -$512K | 0.84% | 17 |
|
|
2023
Q2 | $4.33M | Sell |
28,545
-207
| -0.7% | -$31.2K | 0.8% | 20 |
|
|
2023
Q1 | $4.28M | Sell |
28,752
-522
| -2% | -$74.6K | 0.85% | 18 |
|
|
2022
Q4 | $4.44M | Sell |
29,274
-237
| -0.8% | -$33.2K | 0.92% | 14 |
|
|
2022
Q3 | $3.73M | Sell |
29,511
-1,412
| -5% | -$201K | 0.82% | 16 |
|
|
2022
Q2 | $4.45M | Sell |
30,923
-11,576
| -27% | -$1.74M | 0.88% | 16 |
|
|
2022
Q1 | $6.49M | Sell |
42,499
-12,385
| -23% | -$1.94M | 0.8% | 19 |
|
|
2021
Q4 | $8.98M | Sell |
54,884
-19,710
| -26% | -$2.93M | 0.7% | 22 |
|
|
2021
Q3 | $10.4M | Sell |
74,594
-1,902
| -2% | -$270K | 0.78% | 17 |
|
|
2021
Q2 | $10.3M | Sell |
76,496
-12,114
| -14% | -$1.64M | 0.74% | 20 |
|
|
2021
Q1 | $12M | Buy |
88,610
+2,176
| +3% | +$284K | 0.82% | 17 |
|
|
2020
Q4 | $12M | Buy |
86,434
+6,468
| +8% | +$904K | 0.93% | 14 |
|
|
2020
Q3 | $11.1M | Sell |
79,966
-12,981
| -14% | -$1.72M | 1.07% | 12 |
|
|
2020
Q2 | $11.1M | Buy |
92,947
+18,523
| +25% | +$2.16M | 1.05% | 10 |
|
|
2020
Q1 | $8.19M | Buy |
74,424
+4,295
| +6% | +$515K | 1.05% | 15 |
|
|
2019
Q4 | $8.74M | Sell |
70,129
-7,542
| -10% | -$923K | 0.92% | 13 |
|
|
2019
Q3 | $9.67M | Buy |
77,671
+3,469
| +5% | +$410K | 1% | 12 |
|
|
2019
Q2 | $8.76M | Sell |
74,202
-5,523
| -7% | -$589K | 0.95% | 14 |
|
|
2019
Q1 | $8.29M | Sell |
79,725
-5,076
| -6% | -$494K | 0.92% | 14 |
|
|
2018
Q4 | $7.79M | Buy |
84,801
+10,318
| +14% | +$922K | 0.66% | 18 |
|
|
2018
Q3 | $6.6M | Sell |
74,483
-7,297
| -9% | -$597K | 0.53% | 26 |
|
|
2018
Q2 | $6.38M | Sell |
81,780
-23,561
| -22% | -$1.77M | 0.46% | 27 |
|
|
2018
Q1 | $8.35M | Sell |
105,341
-1,340
| -1% | -$112K | 0.56% | 23 |
|
|
2017
Q4 | $9.8M | Buy |
106,681
+4,283
| +4% | +$385K | 0.64% | 18 |
|
|
2017
Q3 | $9.32M | Sell |
102,398
-826
| -0.8% | -$75.2K | 0.62% | 18 |
|
|
2017
Q2 | $9M | Sell |
103,224
-5,988
| -5% | -$528K | 0.62% | 19 |
|
|
2017
Q1 | $9.81M | Buy |
109,212
+8,040
| +8% | +$713K | 0.68% | 17 |
|
|
2016
Q4 | $8.51M | Buy |
+101,172
| New | +$8.62M | 0.93% | 17 |
|
Other funds holding PG
VCM
VPM
Cigna Investments's PG Position: Q1 2026 in Review
Cigna Investments reduced its Procter & Gamble (PG) stake by 1.3% in Q1 2026, selling an estimated $45.2K and leaving 22,337 shares worth $3.23M. The position accounts for 0.5% of the portfolio, ranked #28.
Cigna Investments first reported a position in PG in Q4 2016 and has held it in 38 quarters since. The position peaked at $12M in Q4 2020. 3,984 funds tracked by Wall St. Rank hold PG as of Q1 2026.
- Cigna Investments held 22,337 shares of Procter & Gamble worth $3.23M as of Q1 2026.
- Cigna Investments sold 298 Procter & Gamble shares in Q1 2026, an estimated $45.2K.
- Procter & Gamble made up 0.5% of Cigna Investments's portfolio in Q1 2026, its #28 holding.
- Cigna Investments first reported a position in Procter & Gamble in Q4 2016 and has held it in 38 quarters since.
- Cigna Investments's Procter & Gamble position peaked at $12M in Q4 2020.
- 3,984 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.
Based on Cigna Investments's 13F filing for Q1 2026, filed 11 May 2026.